S100A8 and autoimmune disease: In addition, extracellular S100A8/A9 is a well-established biomarker for many acute and chronic inflammatory disorders, including cardiovascular diseases, autoimmune diseases, and infections (Pruenster et al., 2016; Wang et al., 2018; Jukic et al., 2021).